Intech Biopharm Company Description

Intech Biopharm Corporation engages in developing and manufacturing generic drugs to treat respiratory diseases in Taiwan and internationally.

It owns iLEF (inhaled low ethanol formulation), a metered dose inhaler platform for treating asthma and COPD; and dry powder inhaler, a product comprises of blisters and capsules.

The company offers its products under the SYN006, SYN010, SYN007, Synflutide, Duasma, Synvent, and SYN011 names.

Intech Biopharm Corporation was founded in 2010 and is headquartered in Taipei, Taiwan.

Intech Biopharm Corporation

Country	Taiwan
Founded	2010
Industry	Biotechnology
Sector	Healthcare
Employees	82
CEO	Wei-Shiu Wu

Contact Details

Address: No. 36, Ruiguang Road Taipei, 114 Taiwan
Phone	886 2 7721 8877
Website	intechbiopharm.com

Stock Details

Ticker Symbol	6461
Exchange	Taipei Exchange
Fiscal Year	January - December
Reporting Currency	TWD
ISIN Number	TW0006461007
SIC Code	2834

Key Executives

Name	Position
Wei-Shiu Wu	General Manager
Yan-Qin Zhao	Senior Division Head and Chief Research & Development Officer
Chien-Yiu Yang	Finance Division Head
Hugues Hung	Chief Financial Officer